- Active not recruitingPHASE3
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
This study investigates a new medicine, obexelimab, for Warm Autoimmune Hemolytic Anemia (wAIHA). It aims to see how well it works and if it's safe for people who haven't responded to previous treatments.
For: Warm Autoimmune Hemolytic AnemiaItaly · Poland · Spain - Active not recruitingPHASE2
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
The MoonStone study is looking at a new medicine called obexelimab for people with relapsing multiple sclerosis (MS). It aims to see if obexelimab can help and if it's safe. Participants will get either the new medicine or a dummy treatment, then everyone will get the new medicine.
For: Relapsing Multiple SclerosisUnited States · Austria · Belgium - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, WITH A SAFETY AND DOSE CONFIRMATION RUN-IN PERIOD, TO EVALUATE THE EFFICACY AND SAFETY OF OBEXELIMAB IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA (SAPHIARE)
This study is testing a new medicine called Obexelimab for people with Warm Autoimmune Hemolytic Anemia (wAIHA). It wants to see if the medicine is safe and helps improve their red blood cell levels compared to a dummy treatment.
For: WARM AUTOIMMUNE HEMOLYTIC ANEMIASpain · Italy · Poland - Active not recruitingPHASE3
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
This study is testing a new medicine called obexelimab for IgG4-related disease. It wants to see if this medicine can stop flare-ups of the condition and if it's safe to use. Half the participants will get the new medicine and the other half will get a dummy medicine.
For: IgG4 Related DiseaseUnited States · Argentina · Canada